CBB
BMRN icon

Citizens Business Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History

Citizens Business Bank’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,053
Closed -$667K – 137
2022
Q2 		$667K Sell
8,053
-144
-2% -$11.5K 0.09% 175
2022
Q1 		$632K Hold
8,197
– – 0.08% 187
2021
Q4 		$724K Hold
8,197
– – 0.09% 187
2021
Q3 		$634K Hold
8,197
– – 0.08% 187
2021
Q2 		$684K Buy
8,197
+3,469
+73% +$275K 0.09% 185
2021
Q1 		$357K Sell
4,728
-18,742
-80% -$1.53M 0.05% 213
2020
Q4 		$2.06M Sell
23,470
-15,459
-40% -$1.23M 0.3% 98
2020
Q3 		$2.96M Buy
38,929
+942
+2% +$95.3K 0.5% 51
2020
Q2 		$4.68M Sell
37,987
-469
-1% -$46.6K 0.83% 26
2020
Q1 		$3.25M Buy
38,456
+219
+0.6% +$18.9K 0.67% 35
2019
Q4 		$3.23M Buy
38,237
+13,030
+52% +$984K 0.53% 47
2019
Q3 		$1.7M Sell
25,207
-320
-1% -$24.6K 0.28% 90
2019
Q2 		$2.19M Sell
25,527
-944
-4% -$80.8K 0.36% 70
2019
Q1 		$2.35M Buy
26,471
+445
+2% +$41.2K 0.41% 61
2018
Q4 		$2.22M Sell
26,026
-1,300
-5% -$124K 0.43% 57
2018
Q3 		$2.65M Sell
27,326
-560
-2% -$55.9K 0.44% 59
2018
Q2 		$2.63M Buy
27,886
+9,488
+52% +$831K 0.46% 57
2018
Q1 		$1.49M Sell
18,398
-239
-1% -$20.5K 0.26% 105
2017
Q4 		$1.66M Sell
18,637
-843
-4% -$73.3K 0.27% 91
2017
Q3 		$1.81M Sell
19,480
-657
-3% -$58.1K 0.3% 83
2017
Q2 		$1.83M Buy
+20,137
New +$1.83M 0.3% 81

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Citizens Business Bank's BMRN Position: Q3 2022 in Review

Citizens Business Bank sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2022, closing a stake of 8,053 shares — an estimated $667K sold.

Citizens Business Bank first reported a position in BMRN in Q2 2017 and held it in 21 quarters. The position peaked at $4.68M in Q2 2020. 551 funds tracked by Wall St. Rank hold BMRN as of Q3 2022.

  • Citizens Business Bank reported no remaining BioMarin Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Citizens Business Bank sold 8,053 BioMarin Pharmaceuticals shares in Q3 2022, an estimated $667K.
  • Citizens Business Bank first reported a position in BioMarin Pharmaceuticals in Q2 2017 and held it in 21 quarters.
  • Citizens Business Bank's BioMarin Pharmaceuticals position peaked at $4.68M in Q2 2020.
  • 551 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2022.

Based on Citizens Business Bank's 13F filing for Q3 2022, filed 4 Nov 2022.